CYBNHelus Pharma Inc.
- Market cap
- not reported
- Latest close
- not reported
- Sector
- not reported
- Industry
- not reported
Values marked — are missing or out of date.
Cluster
2 insiders bought $1.39M between Sep 21 – Sep 29.
Under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-09-09
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Glavine PaulChief Growth Officer | Sep 30 | Oct 1 | A | 248,000 | not reported | not reported | 4,750,191 | No | Form 4 |
| So Eric H. L. | Sep 30 | Oct 1 | A | 248,000 | not reported | not reported | 4,713,014 | No | Form 4 |
| Cavers GregChief Financial Officer | Sep 29 | Oct 1 | P | 3,000 | $12.91 | Purchase +$38,730 | 3,000 | No | Form 4 |
| Halstead MichaelChief Executive Officer | Sep 21 | Sep 21 | P | 100,000 | $13.47 | Purchase +$1,347,000 | 168,568 | No | Form 4 |
| So Eric H. L.Executive Chair | Sep 8 | Sep 11 | P | 100,000 | $12.39 | Purchase +$1,239,000 | 4,465,014 | No | Form 4 |
| Glavine PaulChief Growth Officer | Sep 8 | Sep 11 | P | 100,000 | $12.47 | Purchase +$1,247,000 | 4,271,252 | No | Form 4 |
| Glavine PaulChief Growth Officer | Sep 8 | Sep 11 | P | 100,000 | $12.47 | Purchase +$1,247,000 | 4,271,252 | No | Form 4 |
| So Eric H. L.Executive Chair | Sep 4 | Sep 10 | P | 100,000 | $12.09 | Purchase +$1,209,000 | 4,365,014 | No | Form 4 |
| Glavine PaulChief Growth Officer | Sep 3 | Sep 10 | P | 100,000 | $11.78 | Purchase +$1,178,000 | 4,171,252 | No | Form 4 |
| So Eric H. L.Executive Chair | Sep 1 | Sep 9 | P | 95,000 | $11.81 | Purchase +$1,121,950 | 4,265,014 | No | Form 4 |
| Glavine PaulChief Growth Officer | Aug 31 | Sep 9 | P | 90,000 | $11.59 | Purchase +$1,043,100 | 4,071,252 | No | Form 4 |